Alaethes Wealth’s Sanofi SNY Stock Holding History

Alaethes Wealth’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300	Closed	-$15K	–	261
2022 Q1	$15K	Hold	300	–	–	0.01%	200
2021 Q4	$15K	Hold	300	–	–	0.01%	181
2021 Q3	$14K	Hold	300	–	–	0.01%	178
2021 Q2	$16K	Buy	+300	New	+$15.7K	0.01%	168

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alaethes Wealth's SNY Position: Q2 2022 in Review

Alaethes Wealth sold out of Sanofi (SNY) in Q2 2022, closing a stake of 300 shares — an estimated $15K sold.

Alaethes Wealth first reported a position in SNY in Q2 2021 and held it in 4 quarters. The position peaked at $16K in Q2 2021. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

Alaethes Wealth reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
Alaethes Wealth sold 300 Sanofi shares in Q2 2022, an estimated $15K.
Alaethes Wealth first reported a position in Sanofi in Q2 2021 and held it in 4 quarters.
Alaethes Wealth's Sanofi position peaked at $16K in Q2 2021.
656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.